Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Articles

Page Path
HOME > J Korean Cancer Assoc > Volume 30(6); 1998 > Article
Original Article
A Comparison of the Acute Antiemetic Effect of Tropisetron with Ondansetron in Patients Receiving Cisplatin
Sung Tae Cho, Bo Kwon Hwang, Chan Kyu Kim, Bong Min Ko, Sung Han Bae, Jong Dae Bong, Cheol Woo Lee, Sung Kyu Park, Jong Ho Won, Seung Ho Baick, Dae Sik Hong, Hee Sook Park
Journal of the Korean Cancer Association 1998;30(6): 1240-1248.
1Department of Internal Medicine, Soonchunhyang University College of Medicine, Seoul, Korea.
2Institute for Clinical Molecular Biology Reserch, Soonchunhyang University College of Medicine, Seoul, Korea.
  • 2,744 Views
  • 19 Download
  • 0 Crossref
  • 0 Scopus
prev next

PURPOSE
Tropisetron, a new specific 5-hydroxytryptamine3 (5-HT3) receptor antagonist, is an effective antiemetic agent in the control of chemotherapy induced emesis with a long half life and bioavailablity. We compared the efficacy and safefy of Tropisetron and ondansetron to control emesis induced by highly emetogenic chemotherapeutics (cisplatin > or = 50 mg/m(2)).
MATERIALS AND METHODS
Twenty-one patients were administered in a randomized, open, crossover study and received either tropisetron plus dexamethasone or ondansetron plus dexamethasone during two successive cycles of chemotherapy.
RESULTS
Control of acute emesis with either tropisetron or ondansetron was 100% vs 95.2%, and 80.9% vs 76.2% in control of delayed emesis. Both severity and duration of nausea showed no statistically significant difference between tropisetron and ondansetron. Poor appetite and headache were most common side effects in both groups.
CONCLUSION
There was no significant difference in efficacy for control of emesis and nausea between tropisetron and ondansetron in cisplatin-based chemotherapy.

  • Cite
    CITE
    export Copy Download
    Close
    Download Citation
    Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

    Format:
    • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
    • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
    Include:
    • Citation for the content below
    A Comparison of the Acute Antiemetic Effect of Tropisetron with Ondansetron in Patients Receiving Cisplatin
    J Korean Cancer Assoc. 1998;30(6):1240-1248.
    Close

Cancer Res Treat : Journal of the Korean Cancer Association
Close layer
TOP